Lv4
680 积分 2025-11-18 加入
Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes. Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes
2天前
已完结
Effects of administration of an anti-cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies
21天前
已完结
A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus
21天前
已关闭
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
26天前
已完结
STAT3 degraders inhibit cellular activation, cytokine production, and Th17 development, resulting in inhibition of autoimmunity in the MOG-EAE model of CNS inflammation
1个月前
已关闭
OP0080 STAT3 DEGRADERS INHIBIT Th17 DEVELOPMENT AND CYTOKINE PRODUCTION RESULTING IN PROFOUND INHIBITION OF COLLAGEN-INDUCED AUTOIMMUNE MURINE ARTHRITIS
1个月前
已完结
Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice
1个月前
已完结
Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3
1个月前
已完结
Targeting the STAT3 pathway with STAT3 degraders
1个月前
已完结
STAT3 degraders inhibit cellular activation, cytokine production, and Th17 development, resulting in inhibition of autoimmunity in the MOG-EAE model of CNS inflammation
1个月前
已关闭